Literature DB >> 16847214

A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.

Don Mehrabi, Amit G Pandya.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847214     DOI: 10.1001/archderm.142.7.927

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  2 in total

1.  [Off-label indications for topical tacrolimus].

Authors:  U R Hengge
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

2.  The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis.

Authors:  Yujie Dong; Qi Yang; Baofeng Guo; Jiajing Zhu; Xiaojie Sun
Journal:  Arch Dermatol Res       Date:  2020-08-12       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.